Human antibody Fc deamidation in vivo
Authors:
- Y. Diana LiuYLY. Diana Liu
- Jian Zhang van EnkJEJian Zhang van Enk
- Gregory C. FlynnGFGregory C. Flynn
- 1 October 2009
- journal article
- clinical trial
- Published by Elsevier in Biologicals
- Vol. 37 (5) , 313-322
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Human IgG2 Antibody Disulfide Rearrangement in VivoJournal of Biological Chemistry, 2008
- Identification and quantification of degradations in the Asp–Asp motifs of a recombinant monoclonal antibodyJournal of Pharmaceutical and Biomedical Analysis, 2008
- Spontaneous asparaginyl deamidation of canine milk lysozyme under mild conditionsProteins: Structure, Function, and Bioinformatics, 2008
- Characterization of a complex glycoprotein whose variable metabolic clearance in humans is dependent on terminal N-acetylglucosamine contentBiologicals, 2008
- In Vivo Deamidation Characterization of Monoclonal Antibody by LC/MS/MSAnalytical Chemistry, 2005
- Structure‐dependent nonenzymatic deamidation of glutaminyl and asparaginyl pentapeptidesChemical Biology & Drug Design, 2004
- Prediction of primary structure deamidation rates of asparaginyl and glutaminyl peptides through steric and catalytic effectsChemical Biology & Drug Design, 2004
- Pharmacokinetics of total immunoglobulin G and immunoglobulin G subclasses in patients undergoing replacement therapy for primary immunodeficiency syndromesVox Sanguinis, 2003
- Crystallographic structure of an intact IgG1 monoclonal antibody 1 1Edited by I. A. WilsonJournal of Molecular Biology, 1998
- Deamidation of the asparaginyl‐glycyl sequenceInternational Journal of Peptide and Protein Research, 1986